Phase II Study of the Frontline Hyper-CVAD in Combination with Ofatumumab for Adult Patients (pts) with CD-20 Positive Acute Lymphoblastic Leukemia (ALL)
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | S. O'brien | N. Jain | J. Chahoud | K. Sasaki | Paul B. Koller | R. Garris | Maria R. Khouri | D. Thomas | Heather M Schroeder | Rebecca E. Garris